Sean Maduck - 07 Jul 2021 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Role
Chief Commercial Officer
Signature
By: /s/ Joseph Douglas Lyon, Attorney-in-Fact for Sean Nicholas Maduck
Issuer symbol
CORT
Transactions as of
07 Jul 2021
Net transactions value
-$472,442
Form type
4
Filing time
09 Jul 2021, 17:29:28 UTC
Previous filing
02 Jun 2025
Next filing
14 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CORT Common Stock Options Exercise $82,250 +25,000 +83% $3.29* 55,024 07 Jul 2021 Direct F1
transaction CORT Common Stock Sale $554,692 -25,000 -45% $22.19 30,024 07 Jul 2021 Direct F1, F2
holding CORT Common Stock 10,000 07 Jul 2021 See Footnote F3
holding CORT Common Stock 10,000 07 Jul 2021 See Footnote F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CORT Stock Option (Right to Buy) Options Exercise $0 -25,000 -11% $0.000000 197,602 07 Jul 2021 Common Stock 25,000 $3.29 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction was made pursuant to a 10b5-1 plan in effect at the time of the transaction.
F2 Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $22.17 to $22.25 per share. Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.
F3 Represents the shares held by Duckhill Capital, LLC of which the reporting person is President and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.
F4 Represents the shares held by Sean and Molly Maduck Living Trust of which the reporting person is a co-trustee.
F5 Fully exercisable.